• S&P 500: 1,342.64
  • Change: -0.69%
$25.44 -0.38 (-1.47%)
2/10/2012 4:00 PM

Acorda Therapeutics, Inc. (NASDAQ:ACOR)

CAPS Rating: 2 out of 5

A commercial-stage biopharmaceutical company dedicated to the identification, development & commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the CNS.

Current Price $25.44 Mkt Cap $1.01B
Open $25.63 P/E Ratio 59.50
Prev. Close $25.82 Div. (Yield) N/A (N/A)
Daily Range $25.07 - $26.06 Volume 625,435
52-Wk Range $18.36 - $33.48 Avg. Daily Vol. 0

Caps

How do you think ACOR will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

181 Outperform
95 Underperform
 

All-Star Players

48 Outperform
34 Underperform
 

Wall Street

12 Outperform
2 Underperform
 

Top ACOR Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.27)
Submitted October 14, 2010

Acorda seems to be wandering in a sine wave pattern as alternatively optimistic and pessimistic views of the commercial potential of their multiple sclerosis drug Ampyra. Ampyra is far from a proven winner but the share price will likely rebound with… More

Hogty (41.49)
Submitted September 01, 2009

Overvalued. If you want in on the future of CNS research and production invest in a broader, safer buy like STEM. They will benefit from the production and storage regardless of who comes up with the new tech. Short the fall. Not sure when or if I… More

ACOR VS S&P 500 (SPY)

Fools bullish on ACOR are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ACOR.

Recs

0
Member Avatar portefeuille (99.81) Submitted: 12/15/2011 9:17:24 PM : Outperform Start Price: $21.19 ACOR Score: +2.58

There are currently 70 ACOR shares in my "fund" with break-even of around 8.18 USD.
http://caps.fool.com/Blogs/fund-trades/678775.

Recs

0
Member Avatar Haugurafpeningum (98.39) Submitted: 11/8/2011 2:28:44 AM : Outperform Start Price: $23.23 ACOR Score: +3.65

Technical Monthly

Recs

0
Member Avatar jsgant13 (96.11) Submitted: 2/8/2011 9:38:25 PM : Outperform Start Price: $22.53 ACOR Score: +11.29

sac

Leaderboard

Find the members with the highest scoring picks in ACOR.

Score Leader

Jeffreyw

Jeffreyw (98.17) Score: +228.53

Risky and volatile, there is much promise in the research and great demand in this area for successful therapies to treat spinal injuries, MS and central nervous system disorders.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ignorant1 66.65 10/2/2006 Outperform 1Y $8.88 +186.49% +6.81% +179.67 0 Comment
kaiseras < 20 10/2/2006 Outperform 3M $8.88 +186.49% +6.81% +179.67 0 Comment
EddieBhai 25.43 9/29/2006 Outperform 1Y $9.27 +174.43% +6.60% +167.83 0 Comment
fool1e7 58.75 9/29/2006 Outperform 3W $9.60 +165.00% +6.54% +158.46 0 Comment
pkurkjian 86.28 9/27/2006 Outperform 3W $10.30 +146.99% +6.90% +140.09 0 Comment
papabearof5 < 20 10/4/2006 Outperform 3W $11.00 +131.27% +6.07% +125.21 0 Comment
stockquoter < 20 9/26/2006 Outperform 1Y $11.09 +129.40% +7.02% +122.37 0 Comment
hamzavi < 20 10/5/2006 Outperform 3M $12.60 +101.90% +5.58% +96.32 0 Comment
benariel < 20 10/6/2006 Outperform NS $13.19 +92.87% +5.74% +87.13 0 Comment
wmatin 75.88 10/9/2006 Outperform 3W $14.92 +70.51% +5.75% +64.76 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackMKMPartners 97.67 1/9/2012 Outperform NS $26.47 -3.89% +5.07% -8.96 0 Comment
TrackZacks 71.09 11/5/2010 Outperform 3M $27.04 -2.48% -3.49% +1.01 11/23/2010 @ $26.37 1 Comment
TrackStifel 96.18 9/9/2010 Outperform NS $33.35 -23.72% +20.34% -44.06 0 Comment
TrackRWBaird 90.56 9/7/2010 Outperform NS $33.47 -22.20% +13.04% -35.24 12/14/2010 @ $26.04 0 Comment
TrackJimCramer 78.17 2/9/2010 Outperform 3W $29.99 -15.17% +25.31% -40.49 0 Comment
trackmerriman 70.89 10/15/2009 Outperform NS $25.07 +1.48% +23.52% -22.04 0 Comment
TrackRodmanRen < 20 10/12/2009 Underperform NS $17.72 +43.57% +24.55% -19.01 0 Comment
TrackPiperJaff 89.09 8/5/2009 Outperform NS $24.85 +2.37% +33.97% -31.60 0 Comment
TrackLeerinkSwan 88.11 7/2/2009 Outperform NS $24.90 +2.17% +48.15% -45.98 0 Comment
TrackZacks 71.09 4/23/2009 Outperform 3M $21.89 +48.56% +27.95% +20.61 6/24/2010 @ $32.52 1 Comment
trackhapoalim < 20 3/24/2009 Outperform NS $26.70 -4.72% +67.11% -71.83 0 Comment
TrackFTNEquityCa 85.00 3/12/2009 Outperform NS $25.25 +0.75% +87.69% -86.94 0 Comment
TrackRBCCapMkts 93.36 11/7/2008 Outperform NS $20.22 +25.82% +48.22% -22.40 0 Comment
TrackRWBaird 90.56 11/3/2008 Outperform NS $21.13 +44.39% +11.83% +32.56 2/4/2010 @ $30.51 0 Comment
TrackZacks 71.09 6/4/2008 Underperform 3M $30.15 -39.73% -29.35% +10.38 10/8/2008 @ $18.17 1 Comment
TrackIcahn 68.27 9/30/2007 Outperform NS $18.35 +19.67% -4.17% +23.85 12/31/2007 @ $21.96 1 Comment
TrackFortisBank < 20 6/21/2007 Outperform NS $17.87 +21.32% -29.07% +50.39 10/2/2008 @ $21.68 0 Comment
TrackBofASec 96.91 6/19/2007 Outperform NS $19.60 +29.80% -7.20% +37.00 0 Comment
TrackDeutscheSec 90.44 4/12/2007 Outperform NS $23.50 +8.26% -1.76% +10.02 0 Comment
TrackFBRCapitalM 84.63 4/11/2007 Outperform NS $21.37 +41.79% -9.07% +50.86 6/23/2008 @ $30.30 0 Comment
TrackMorganJos 56.19 2/21/2007 Underperform NS $23.40 +8.72% -2.06% -10.78 0 Comment
TrackJimCramer 78.17 10/12/2006 Underperform 3W $17.12 +75.18% -21.59% -96.77 2/10/2010 @ $29.99 0 Comment
TrackPiperJaff 89.09 9/29/2006 Outperform NS $9.73 +163.62% -30.73% +194.35 7/1/2009 @ $25.65 0 Comment
TrackBofASec 96.91 9/26/2006 Outperform NS $10.09 +131.91% +9.84% +122.07 2/21/2007 @ $23.40 0 Comment
TrackLazardCapit 78.92 9/26/2006 Outperform NS $10.09 +152.13% +7.64% +144.49 0 Comment

Featured Broker Partners